Words by Rosie Wilson

Lumenis Ltd. has announced that it supported a successful mission to treat children with burn injuries in Armenia. The initiative provided access to treatment for patients in need, but also helped to build a sustainable burn injury care network in Armenia.

Lumenis is the world’s largest energy-based medical device company for aesthetic, surgical and ophthalmology applications. The Lumenis UltraPulse – which is the most powerful CO2 laser system for scar evision – was used for the mission. The UltraPulse has been used in similar endeavours in Russia, China and Vietnam, and is also used for treating soldiers injured in battle, for example in the VA hospitals in the USA.

The project was headed by R. Rox Anderson, MD, Director of the Wellman Centre for Photomedicine and Professor of Dermatology at Harvard Medical School. He said:

“Unfortunately, sometimes the most effective and innovative healthcare technologies don’t get to the patients who need them the most. We’re determined to change that. Children with burn injuries – whether they live in the suburbs of New York City or a small village in Armenia – should have access to treatments like UltraPulse.”

Dr. Hrachaya Arshakyan, chief of the plastic surgery department, said:

“It is important to remember that scars do not just affect a patient’s appearance. For many patients with burn injuries, chronic pain and physical discomfort from their scars create a major quality of life burden. Range of motion can also be compromised dye to severe scarring. These complex cases require advanced laser technologies like UltraPulse with SCAARFX that can penetrate deep into the skin, helping to aid healthy skin regeneration.”

Tzipi Ozer-Armin, CEO of Lumenis, said:

“Lumenis is honoured to be supporting this important mission to help children in Armenia. This approach used by Dr. Anderson and the Wellman Centre creates enduring change by empowering local medical leaders. The benefits of these missions last for many years and continue to grow as more physicians are trained on the technology and more patients receive access to life-changing treatments.”

For more information on Lumenis products and news, please visit www.lumenis.com